公开(公告)号：US20230121497A1

公开(公告)日：2023-04-20

申请号：US17795929

申请日：2021-01-29

Applicant: Foghorn Therapeutics Inc.

Inventor： Rishi G. VASWANI ,  David S. HUANG ,  Kevin J. WILSON ,  Shawn E.R. SCHILLER ,  Neville John ANTHONY

IPC: C07D471/04 ,  C07D403/14 ,  C07D401/14 ,  C07D413/14 ,  C07D403/12 ,  C07D405/14 ,  C07D417/14

Abstract: The present disclosure features compounds useful for the treatment of BAF complex-related disorders.

公开(公告)号：US20210230154A1

公开(公告)日：2021-07-29

申请号：US17162103

申请日：2021-01-29

Applicant: Foghorn Therapeutics Inc.

Inventor： Rishi G. VASWANI ,  David S. HUANG

IPC: C07D417/14 ,  A61P35/00 ,  A61P35/02

Abstract: The present disclosure features compounds useful for the treatment of BAF complex-related disorders.

公开(公告)号：US20250066354A1

公开(公告)日：2025-02-27

申请号：US18926578

申请日：2024-10-25

Applicant: Foghorn Therapeutics Inc.

Inventor： Shawn E.R. SCHILLER ,  Solymar NEGRETTI ,  David S. HUANG ,  Kevin J. WILSON ,  Melek Nihan UCISIK ,  Richard CALDWELL

IPC: C07D471/04 ,  A61K45/06 ,  C07D519/00

Abstract: The present disclosure features compounds of Formula I, or pharmaceutically acceptable salts thereof, and formulations containing the same. Methods of treating BAF complex-related disorders, such as cancer, are also disclosed.

公开(公告)号：US20230365560A1

公开(公告)日：2023-11-16

申请号：US18315526

申请日：2023-05-11

Applicant: Foghorn Therapeutics Inc.

Inventor： Shawn E.R. SCHILLER ,  Solymar NEGRETTI ,  David S. HUANG ,  Kevin J. WILSON ,  Melek Nihan UCISIK ,  Richard CALDWELL

IPC: C07D471/04 ,  A61K45/06 ,  C07D519/00

CPC classification number: C07D471/04 ,  A61K45/06 ,  C07D519/00 ,  C07B2200/05

Abstract: The present disclosure features compounds of Formula I,




or pharmaceutically acceptable salts thereof, and formulations containing the same. Methods of treating BAF complex-related disorders, such as cancer, are also disclosed.

公开(公告)号：US20230079819A1

公开(公告)日：2023-03-16

申请号：US17425140

申请日：2020-01-29

Applicant: Foghorn Therapeutics Inc.

Inventor： Rishi G. VASWANI ,  Neville John ANTHONY ,  David Simon MILLAN ,  Shawn E.R. SCHILLER ,  Kevin J. WILSON ,  David S. HUANG

IPC: C07D417/14 ,  A61P35/00 ,  C07D498/04 ,  C07D417/12 ,  C07D487/04 ,  C07D491/08 ,  C07D471/04 ,  C07D491/107 ,  C07D491/048

Abstract: The present disclosure features compounds useful for the treatment of BAF complex-related disorders.

公开(公告)号：US20240101550A1

公开(公告)日：2024-03-28

申请号：US18373518

申请日：2023-09-27

Applicant: FOGHORN THERAPEUTICS INC.

Inventor： Rishi G. VASWANI ,  David S. HUANG

IPC: C07D417/14 ,  A61P35/00 ,  A61P35/02

CPC classification number: C07D417/14 ,  A61P35/00 ,  A61P35/02

Abstract: The present disclosure features compounds useful for the treatment of BAF complex-related disorders.

公开(公告)号：US20230416248A1

公开(公告)日：2023-12-28

申请号：US18252228

申请日：2021-11-10

Applicant: Foghorn Therapeutics Inc.

Inventor： Kevin J. WILSON ,  Solymar NEGRETTI ,  Shawn E.R. SCHILLER ,  Rishi G. VASWANI ,  David S. HUANG ,  Johannes H. VOIGT

IPC: C07D471/04 ,  C07D519/00 ,  A61P35/00

CPC classification number: C07D471/04 ,  C07D519/00 ,  A61P35/00

Abstract: The present disclosure features compounds useful for the treatment of BAF complex-related disorders.

公开(公告)号：US20230129003A1

公开(公告)日：2023-04-27

申请号：US17963576

申请日：2022-10-11

Applicant: Foghorn Therapeutics Inc.

Inventor： Rishi G. VASWANI ,  David S. HUANG

IPC: C07D417/14 ,  A61P35/02 ,  A61P35/00

Abstract: The present disclosure features compounds useful for the treatment of BAF complex-related disorders.